City Holding Co’s iBio IBIO Stock Holding History

City Holding Co’s Portfolio IBIO Stock Details IBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-4	Closed	-$3	–	606
2025 Q3	$3	Hold	4	–	–	﹤0.01%	583
2025 Q2	$3	Hold	4	–	–	﹤0.01%	485
2025 Q1	$16	Hold	4	–	–	﹤0.01%	608
2024 Q4	$9	Hold	4	–	–	﹤0.01%	468
2024 Q3	$8	Hold	4	–	–	﹤0.01%	462
2024 Q2	$8	Hold	4	–	–	﹤0.01%	459
2024 Q1	$16	Hold	4	–	–	﹤0.01%	481
2023 Q4	$5	Hold	4	–	–	﹤0.01%	490
2023 Q3	$24	Hold	4	–	–	﹤0.01%	505
2023 Q2	$48	Hold	4	–	–	﹤0.01%	508
2023 Q1	$165	Hold	4	–	–	﹤0.01%	516
2022 Q4	$35	Hold	4	–	–	﹤0.01%	517
2022 Q3	$0	Hold	4	–	–	﹤0.01%	525
2022 Q2	$1K	Hold	4	–	–	﹤0.01%	496
2022 Q1	$1K	Hold	4	–	–	﹤0.01%	500
2021 Q4	$1K	Hold	4	–	–	﹤0.01%	498
2021 Q3	$2K	Hold	4	–	–	﹤0.01%	468
2021 Q2	$3K	Hold	4	–	–	﹤0.01%	474
2021 Q1	$3K	Buy	+4	New	+$3.48K	﹤0.01%	475

Other funds holding IBIO

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

AAA

Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return

LGM

Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return

FLSM

Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SCM

Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

City Holding Co's IBIO Position: Q4 2025 in Review

City Holding Co sold out of iBio (IBIO) in Q4 2025, closing a stake of 4 shares — an estimated $3 sold.

City Holding Co first reported a position in IBIO in Q1 2021 and held it in 19 quarters. The position peaked at $3K in Q2 2021. 50 funds tracked by Wall St. Rank hold IBIO as of Q4 2025.

City Holding Co reported no remaining iBio position as of Q4 2025 after selling out during the quarter.
City Holding Co sold 4 iBio shares in Q4 2025, an estimated $3.
City Holding Co first reported a position in iBio in Q1 2021 and held it in 19 quarters.
City Holding Co's iBio position peaked at $3K in Q2 2021.
50 funds tracked by Wall St. Rank held iBio as of Q4 2025.

Based on City Holding Co's 13F filing for Q4 2025, filed 22 Jan 2026.